JPM
JPMorgan Chase & Co.
JPM has a slight edge over PRK overall, supported by stronger fundamentals and stronger modeled upside.
PRK
Park National Corporation
PRK offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
PRK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
PRK's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like PRK.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
PRK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 13x | $145 | -18% |
| Forward | 13x | $176 | — |
| Fair | 15x | $172 | -2.7% |
| Current | 16x | $176 | — |
| Expensive | 17x | $196 | +11% |
Historical ranges are pointers, not guarantees.
PRK has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
PRK Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
PRK has the edge over JPM on the outlook, with more favorable valuation expectations.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
PRK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.16 | +16% |
| Q3 2026 | $11.37 | +4.6% |
| Q2 2026 | $11.16 | +8.3% |
| Q1 2026 | $10.90 | +12% |
| Q4 2025 | $11.11 | +19% |
| Q3 2025 | $10.87 | +29% |
| Q2 2025 | $10.30 | +23% |
| Q1 2025 | $9.75 | +23% |
| Q4 2024 | $9.32 | +19% |
PRK has the edge over JPM on earnings, with stronger typical year-over-year growth.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over PRK on profitability, with a higher operating margin.
PRK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $177.4M | +25% |
| Q2 2026 | $178.4M | +26% |
| Q1 2026 | $159.5M | +23% |
| Q4 2025 | $144.3M | +7.3% |
| Q3 2025 | $141.6M | +2.9% |
| Q2 2025 | $141.2M | +11% |
| Q1 2025 | $130.1M | +6.8% |
| Q4 2024 | $134.5M | +22% |
PRK has the edge over JPM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -1.1 points |
| Q2 2026 | 41% | -1.2 points |
| Q1 2026 | 32% | -7 points |
| Q4 2025 | 37% | +1.3 points |
| Q3 2025 | 41% | +7.1 points |
| Q2 2025 | 42% | +3.9 points |
| Q1 2025 | 39% | +4.5 points |
| Q4 2024 | 35% | +8.3 points |
PRK's operating margin was 40% last quarter, down 1.1 points from the same quarter a year ago.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
PRK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $58.4M | +14% |
| Q2 2026 | $50.5M | +4.4% |
| Q1 2026 | $26.6M | -28% |
| Q4 2025 | $55.7M | +18% |
| Q3 2025 | $51.1M | +21% |
| Q2 2025 | $48.4M | -0.8% |
| Q1 2025 | $36.8M | +17% |
| Q4 2024 | $47.1M | -9.2% |
PRK has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over PRK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
PRK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +1.1K shares |
| 1 year | +12% | +2M shares |
| 3 years | +12% | +2M shares |
| 5 years | +11% | +1.8M shares |
| Available history | +11% | +1.8M shares |
PRK has 18M diluted shares, up 12% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | $5.2M |
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
PRK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.5x | Net Cash |
| Q2 2026 | -1.8x | Net Cash |
| Q1 2026 | -3.5x | Net Cash |
| Q4 2025 | -0.3x | Net Cash |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | 0.4x | Very low |
| Q1 2025 | 0.2x | Very low |
| Q4 2024 | 2.1x | Moderate |
PRK has the edge over JPM on leverage, with a lower net debt burden relative to earnings.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
PRK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 13.6 | Oversold |
PRK's weekly RSI is 45 (neutral) and its Stochastic is 14 (oversold).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM has the edge over PRK on valuation relative to its sector.
PRK PE vs Financial Services Sector
| Metric | PRK | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 13x | 19% above |
| PE % | 56 | 63 | 7 pts below |
PRK is trading at 16x earnings, a 19% premium to the Financial Services sector's median of 13x.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over PRK on trend strength, trading above more of its moving averages.
PRK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $179.0 | 1.5% below |
| 20 week MA | $188.3 | 6.3% below |
| 50 week MA | $175.5 | 0.5% above |
| 100 week MA | $169.0 | 4.4% above |
| 200 week MA | $150.4 | 17% above |
PRK has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 17% above its 200-week average.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.
PRK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $102.8 | $103.2 | +0.4% |
| 2021 | $103.2 | $138.2 | +34% |
| 2022 | $138.2 | $142.6 | +3.2% |
| 2023 | $142.6 | $132.9 | -6.8% |
| 2024 | $132.9 | $174.1 | +31% |
| 2025 | $174.1 | $157.5 | -9.5% |
| 2026 YTD | $157.5 | $176.4 | +12% |
PRK has the edge over JPM on returns for 2026, with the stronger performance.